Literature DB >> 26491096

NICE approval of new hepatitis drug could result in £700m bill for NHS.

Nigel Hawkes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26491096     DOI： 10.1136/bmj.h5554

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Developing the Disorders of Consciousness Guideline and Challenges of Integrating Shared Decision-Making Into Clinical Practice.

Authors:  Melissa J Armstrong
Journal:  J Head Trauma Rehabil       Date:  2019 May/Jun       Impact factor: 2.710

2.  Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint.

Authors:  Raffaella Ravinetto; Anja De Weggheleire; Thomas P C Dorlo; Sven Francque; An Sokkab; Corinne Pouget; Bruno Meessen; Patricia Tabernero; Paul N Newton; Lut Lynen
Journal:  Trop Med Int Health       Date:  2016-10-17       Impact factor: 2.622

3.  Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank.

Authors:  J McLauchlan; H Innes; J F Dillon; G Foster; E Holtham; S McDonald; B Wilkes; S J Hutchinson; W L Irving
Journal:  Int J Epidemiol       Date:  2017-10-01       Impact factor: 9.685
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.